Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan

Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metfor...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 13; no. 1; p. e0191242
Main Authors Lu, Chieh-Hua, Chung, Chi-Hsiang, Lee, Chien-Hsing, Hsieh, Chang-Hsun, Hung, Yi-Jen, Lin, Fu-Huang, Tsao, Chang-Huei, Hsieh, Po-Shiuan, Chien, Wu-Chien
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 31.01.2018
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0191242

Cover

Loading…
Abstract Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone. In total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1:2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up. At the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group (16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601-0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (>80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without. Patients who have OA and T2DM receiving combination COX-2 inhibitors and metformin therapy associated with lower joint replacement surgery rates than those without and this may be attributable to combination therapy much more decrease pro-inflammatory factors associated than those without metformin therapy.
AbstractList Background Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone. Methods In total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1:2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up. Results At the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group (16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601-0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (>80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without. Conclusions Patients who have OA and T2DM receiving combination COX-2 inhibitors and metformin therapy associated with lower joint replacement surgery rates than those without and this may be attributable to combination therapy much more decrease pro-inflammatory factors associated than those without metformin therapy.
Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone. In total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1:2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up. At the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group (16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601-0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (>80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without.
Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone.In total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1:2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up.At the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group (16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601-0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (>80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without.Patients who have OA and T2DM receiving combination COX-2 inhibitors and metformin therapy associated with lower joint replacement surgery rates than those without and this may be attributable to combination therapy much more decrease pro-inflammatory factors associated than those without metformin therapy.
Background Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone. Methods In total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1:2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up. Results At the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group (16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601–0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (>80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without. Conclusions Patients who have OA and T2DM receiving combination COX-2 inhibitors and metformin therapy associated with lower joint replacement surgery rates than those without and this may be attributable to combination therapy much more decrease pro-inflammatory factors associated than those without metformin therapy.
Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone. In total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1:2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up. At the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group (16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601-0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (>80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without. Patients who have OA and T2DM receiving combination COX-2 inhibitors and metformin therapy associated with lower joint replacement surgery rates than those without and this may be attributable to combination therapy much more decrease pro-inflammatory factors associated than those without metformin therapy.
Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone.BACKGROUNDOsteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on decreasing joint replacement surgery has yet to be elucidated. This study aimed to investigate if the combination of COX-2 inhibitor and metformin therapy in OA with T2DM were associated with lower the rate of joint replacement surgery than COX-2 inhibitor alone.In total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1:2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up.METHODSIn total, 968 subjects with OA and T2DM under COX-2 inhibitor and metformin therapy (case group) between 1 January to 31 December 2000 were selected from the National Health Insurance Research Database of Taiwan, along with 1936 patients were the 1:2 gender-, age-, and index year-controls matched without metformin therapy (control group) in this study. Cox proportional hazards analysis was used to compare the rate of receiving joint replacement surgery during 10 years of follow-up.At the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group (16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601-0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (>80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without.RESULTSAt the end of follow-up, 438 of all enrolled subjects (15.08%) had received the joint replacement surgery, including 124 in the case group (12.81%) and 314 in the control group (16.22%). The case group tended to be associated with lower rate of receiving the joint replacement surgery at the end of follow-up than the control group (p = 0.003). Cox proportional hazards regression (HR) analysis revealed that study subjects under combination therapy with metformin had lower rate of joint replacement surgery (adjusted HR 0.742 (95% CI = 0.601-0.915, p = 0.005)). In the subgroups, study subjects in the combination metformin therapy who were female, good adherence (>80%), lived in the highest urbanization levels of residence, treatment in the hospital center and lower monthly insurance premiums were associated with a lower risk of joint replacement surgery than those without.Patients who have OA and T2DM receiving combination COX-2 inhibitors and metformin therapy associated with lower joint replacement surgery rates than those without and this may be attributable to combination therapy much more decrease pro-inflammatory factors associated than those without metformin therapy.CONCLUSIONSPatients who have OA and T2DM receiving combination COX-2 inhibitors and metformin therapy associated with lower joint replacement surgery rates than those without and this may be attributable to combination therapy much more decrease pro-inflammatory factors associated than those without metformin therapy.
Audience Academic
Author Tsao, Chang-Huei
Lee, Chien-Hsing
Lin, Fu-Huang
Hsieh, Po-Shiuan
Chien, Wu-Chien
Hsieh, Chang-Hsun
Hung, Yi-Jen
Lu, Chieh-Hua
Chung, Chi-Hsiang
AuthorAffiliation 4 Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan, ROC
7 Department of Physiology and Biophysics, National Defense Medical Center, Taipei, Taiwan, ROC
8 Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan, ROC
5 Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
Weill Cornell Medical College Qatar, QATAR
2 Department of Medical Research, National Defense Medical Center, Taipei, Taiwan, ROC
3 School of Public Health, National Defense Medical Center, Taipei, Taiwan, ROC
6 Department of Microbiology & Immunology, National Defense Medical Center, Taipei, Taiwan, ROC
1 Department of Internal Medicine, Division of Endocrinology and Metabolism, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC
AuthorAffiliation_xml – name: 7 Department of Physiology and Biophysics, National Defense Medical Center, Taipei, Taiwan, ROC
– name: Weill Cornell Medical College Qatar, QATAR
– name: 5 Department of Medical Research, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC
– name: 8 Institute of Preventive Medicine, National Defense Medical Center, Taipei, Taiwan, ROC
– name: 3 School of Public Health, National Defense Medical Center, Taipei, Taiwan, ROC
– name: 1 Department of Internal Medicine, Division of Endocrinology and Metabolism, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan, ROC
– name: 6 Department of Microbiology & Immunology, National Defense Medical Center, Taipei, Taiwan, ROC
– name: 2 Department of Medical Research, National Defense Medical Center, Taipei, Taiwan, ROC
– name: 4 Taiwanese Injury Prevention and Safety Promotion Association, Taipei, Taiwan, ROC
Author_xml – sequence: 1
  givenname: Chieh-Hua
  orcidid: 0000-0002-2179-9486
  surname: Lu
  fullname: Lu, Chieh-Hua
– sequence: 2
  givenname: Chi-Hsiang
  surname: Chung
  fullname: Chung, Chi-Hsiang
– sequence: 3
  givenname: Chien-Hsing
  surname: Lee
  fullname: Lee, Chien-Hsing
– sequence: 4
  givenname: Chang-Hsun
  surname: Hsieh
  fullname: Hsieh, Chang-Hsun
– sequence: 5
  givenname: Yi-Jen
  surname: Hung
  fullname: Hung, Yi-Jen
– sequence: 6
  givenname: Fu-Huang
  surname: Lin
  fullname: Lin, Fu-Huang
– sequence: 7
  givenname: Chang-Huei
  surname: Tsao
  fullname: Tsao, Chang-Huei
– sequence: 8
  givenname: Po-Shiuan
  surname: Hsieh
  fullname: Hsieh, Po-Shiuan
– sequence: 9
  givenname: Wu-Chien
  surname: Chien
  fullname: Chien, Wu-Chien
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29385156$$D View this record in MEDLINE/PubMed
BookMark eNqNk21r1EAQx4NU7IN-A9EFQRS8cx-SvaQvhHL4UCgUtIjvlslmc9kj2T13N639Sn5K53pX6ZUikpBsZn___2aGmcNsz3lnsuw5o1MmZuz90o_BQT9dYXhKWcV4zh9lB6wSfCI5FXt31vvZYYxLSgtRSvkk2-eVKAtWyIPs99wPtXWQrHdkfv5jwol1na1t8oGAa8hgUuvDYB2BlIwbIRkS1g_fkqW3LpFgVj1oMxhcI-ZjMh5C6oJNNpIrmzrSWKhNMvGYnJDNWVe2Me9QmoKPK6OTvcTPAZLuTDPRvvMhkZjG5npteQH2CtzT7HELfTTPtu-j7OLTx4v5l8nZ-efT-cnZRMuKp0lBZ01L65pqvAXTEqAVjaFNbjQvpMhLllesqptW6lJAlde0naGG57TGsDjKXm5sV72PalvlqFhVCco4lxyJ0w3ReFiqVbADhGvlwaqbgA8Lhflb3RsldF4WopCclzLXlNeMCpBt2dJCykoDen3YnjbWg2k0FjFAv2O6u-Nspxb-UhUzTKKkaPBmaxD8z9HEpAYbtel7cMaPm_8WpSgrhuire-jD2W2pBWAC1rUez9VrU3VS8GJWzgSVSE0foPBqzGA1tmRrMb4jeLsjQCaZX2kBY4zq9NvX_2fPv--yr--wnYE-ddH347rJ4i744m6l_5b4dhYQON4AGnsyBtMqbdNNs2JqtleMqvXg3RZNrQdPbQcPxfk98a3_P2V_AEtcNFg
CitedBy_id crossref_primary_10_1007_s13679_019_00335_3
crossref_primary_10_3390_jcm11164796
crossref_primary_10_1016_j_ejphar_2022_174903
crossref_primary_10_1515_jbcpp_2022_0252
crossref_primary_10_1016_j_semarthrit_2019_01_005
crossref_primary_10_3389_fphar_2022_952560
crossref_primary_10_3390_life13020437
crossref_primary_10_1177_1947603520962558
crossref_primary_10_1186_s12891_022_05434_2
crossref_primary_10_1177_1759720X221090297
crossref_primary_10_3389_fphar_2021_645842
crossref_primary_10_1038_s41413_023_00301_9
crossref_primary_10_3904_kjim_2021_363
crossref_primary_10_1038_s41598_022_15871_7
crossref_primary_10_3390_biomedicines12081630
crossref_primary_10_1186_s13075_019_1915_x
crossref_primary_10_1177_23259671241311906
crossref_primary_10_3390_jcm11247283
crossref_primary_10_3390_ph14020152
crossref_primary_10_1186_s13075_023_03025_7
crossref_primary_10_3389_fphar_2022_865524
crossref_primary_10_3390_cells10092500
crossref_primary_10_2174_1573397117666211116111738
crossref_primary_10_3390_bioengineering11100972
crossref_primary_10_3390_ijms20133115
crossref_primary_10_1097_MD_0000000000017371
crossref_primary_10_1097_MS9_0000000000002318
crossref_primary_10_1007_s10787_024_01495_y
crossref_primary_10_3390_jcm13010092
crossref_primary_10_2174_1573397114666180717145745
crossref_primary_10_3390_ijms252413695
crossref_primary_10_1038_s41584_024_01178_6
crossref_primary_10_1038_s41584_024_01143_3
crossref_primary_10_1002_jcla_24353
crossref_primary_10_3390_md20100639
crossref_primary_10_1097_MD_0000000000036489
crossref_primary_10_1136_ard_2023_223845
crossref_primary_10_4103_abr_abr_68_19
crossref_primary_10_1016_j_banm_2024_03_002
crossref_primary_10_3390_ijms22137231
crossref_primary_10_56543_aaeeu_2022_1_2_05
crossref_primary_10_1001_jamanetworkopen_2023_3646
crossref_primary_10_3389_fphar_2019_01347
crossref_primary_10_1098_rspb_2021_1942
crossref_primary_10_3390_cells10030681
crossref_primary_10_3390_ph13090234
crossref_primary_10_1186_s13075_020_2129_y
crossref_primary_10_1007_s00296_023_05453_9
crossref_primary_10_1016_j_joca_2020_10_006
crossref_primary_10_4103_jmedsci_jmedsci_157_23
crossref_primary_10_1002_acr_23809
crossref_primary_10_3390_cells11193012
crossref_primary_10_12688_f1000research_22115_1
crossref_primary_10_1111_bcpt_14085
Cites_doi 10.7326/M16-2937
10.1136/ard.2004.023564
10.3389/fendo.2012.00153
10.1159/000449166
10.1002/art.22146
10.1136/ard.2010.146399
10.1136/bmj.h5983
10.18553/jmcp.2016.22.11.1224
10.1016/j.joca.2014.01.003
10.1007/s13167-010-0056-8
10.1016/j.cmpb.2015.11.009
10.3810/pgm.2009.11.2073
10.3899/jrheum.100569
10.1097/MD.0000000000003585
10.1371/journal.pone.0089867
10.1016/j.ejphar.2016.07.012
10.1136/bmjopen-2011-000435
10.1007/s40258-013-0078-1
10.1056/NEJMoa1505467
10.1002/art.24757
10.1136/rmdopen-2015-000077
10.1016/j.joca.2015.04.026
10.1016/j.vaccine.2017.03.078
10.1038/nrm2391
10.1016/S0140-6736(11)60243-2
10.1136/pgmj.2010.146399rep
10.1016/S0140-6736(05)67402-8
10.7326/0003-4819-109-1-18
10.2337/dc12-0924
10.1080/030097401300162969
10.1371/journal.pone.0021368
10.1136/ard.2008.106930
10.1002/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2
ContentType Journal Article
Copyright COPYRIGHT 2018 Public Library of Science
2018 Lu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2018 Lu et al 2018 Lu et al
Copyright_xml – notice: COPYRIGHT 2018 Public Library of Science
– notice: 2018 Lu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2018 Lu et al 2018 Lu et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0191242
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Opposing Viewpoints Resource Center
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agriculture Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList





MEDLINE
MEDLINE - Academic
Agricultural Science Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate COX-2 inhibitor/metformin and joint replacement in osteoarthritis with diabetes
EISSN 1932-6203
ExternalDocumentID 1993012262
oai_doaj_org_article_3c48535622864c02b103a6f8f05669ca
PMC5791980
A525787306
29385156
10_1371_journal_pone_0191242
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
3V.
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
RC3
7X8
PUEGO
5PM
AAPBV
ABPTK
ID FETCH-LOGICAL-c692t-507df0bb0cb0c31c6aaf3de0d4ec25634814919bdf6c83a94b0f707d240b19b3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Sun Oct 01 00:11:35 EDT 2023
Wed Aug 27 01:30:08 EDT 2025
Thu Aug 21 18:28:32 EDT 2025
Thu Sep 04 15:53:39 EDT 2025
Fri Jul 25 11:35:37 EDT 2025
Tue Jun 17 21:14:19 EDT 2025
Tue Jun 10 20:31:16 EDT 2025
Fri Jun 27 04:25:46 EDT 2025
Fri Jun 27 03:45:46 EDT 2025
Thu May 22 21:21:51 EDT 2025
Wed Feb 19 02:42:28 EST 2025
Tue Jul 01 03:28:17 EDT 2025
Thu Apr 24 23:05:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c692t-507df0bb0cb0c31c6aaf3de0d4ec25634814919bdf6c83a94b0f707d240b19b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-2179-9486
OpenAccessLink https://www.proquest.com/docview/1993012262?pq-origsite=%requestingapplication%
PMID 29385156
PQID 1993012262
PQPubID 1436336
PageCount e0191242
ParticipantIDs plos_journals_1993012262
doaj_primary_oai_doaj_org_article_3c48535622864c02b103a6f8f05669ca
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5791980
proquest_miscellaneous_1993383891
proquest_journals_1993012262
gale_infotracmisc_A525787306
gale_infotracacademiconefile_A525787306
gale_incontextgauss_ISR_A525787306
gale_incontextgauss_IOV_A525787306
gale_healthsolutions_A525787306
pubmed_primary_29385156
crossref_citationtrail_10_1371_journal_pone_0191242
crossref_primary_10_1371_journal_pone_0191242
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-31
PublicationDateYYYYMMDD 2018-01-31
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-31
  day: 31
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2018
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References H Waine (ref6) 1961; 7
DJ Hart (ref30) 1995; 22
TE McAlindon (ref13) 2014; 22
F Wolfe (ref15) 2000; 43
CY Chang (ref28) 2014; 9
HH Rau (ref27) 2016; 125
ref39
AD Beswick (ref18) 2012; 2
A Diaz (ref20) 2017; 35
SA Brunton (ref38) 2017; 66
K Louati (ref11) 2015; 1
S Stolpe (ref36) 2016; 22
N Yoshimura (ref8) 2011; 38
DT Felson (ref34) 1988; 109
CH Lu (ref21) 2016; 789
G Schett (ref35) 2009; 60
Y Mikyas (ref37) 2014; 12
(ref24) 2000
CH Chang (ref26) 2011; 6
JW Bijlsma (ref12) 2011; 377
C Xu (ref16) 2016; 95
A Mobasheri (ref10) 2012; 3
GA Hawker (ref33) 2006; 54
RA Puenpatom (ref4) 2009; 121
ST Skou (ref17) 2015; 373
JJ Chamberlain (ref19) 2017; 166
F Berenbaum (ref31) 2012; 88
A Guilherme (ref25) 2008; 9
E Yusuf (ref3) 2010; 69
T Sturmer (ref7) 2001; 30
MC Laiguillon (ref32) 2015; 23
S Derry (ref14) 2012
G Schett (ref29) 2013; 36
C Kim (ref2) 2015; 351
NS Tzeng (ref22) 2016; 47
KG Alberti (ref5) 2005; 366
F Berenbaum (ref9) 2011; 70
S Dahaghin (ref1) 2005; 64
WS Ho Chan (ref23) 2010; 1
23002084 - Diabetes Care. 2013 Feb;36(2):403-9
26535137 - RMD Open. 2015 Jun 02;1(1):e000077
16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62
26631296 - BMJ. 2015 Dec 02;351:h5983
28375408 - J Fam Pract. 2017 Apr;66(4 Suppl):S46-S51
7674240 - J Rheumatol. 1995 Jun;22(6):1118-23
24477429 - Appl Health Econ Health Policy. 2014 Jun;12(3):267-77
24462672 - Osteoarthritis Cartilage. 2014 Mar;22(3):363-88
27397427 - Eur J Pharmacol. 2016 Oct 15;789:60-67
21474484 - Ann Rheum Dis. 2011 Aug;70(8):1354-6
10693878 - Arthritis Rheum. 2000 Feb;43(2):378-85
23199110 - EPMA J. 2010 Dec;1(4):563-85
19644856 - Arthritis Rheum. 2009 Aug;60(8):2381-9
19487215 - Ann Rheum Dis. 2010 Apr;69(4):761-5
22357571 - BMJ Open. 2012 Feb 22;2(1):e000435
17009255 - Arthritis Rheum. 2006 Oct;54(10):3212-20
13782559 - Tufts Folia Med. 1961 Jan-Mar;7:13-9
25987541 - Osteoarthritis Cartilage. 2015 Sep;23(9):1513-22
21324967 - J Rheumatol. 2011 May;38(5):921-30
26488691 - N Engl J Med. 2015 Oct 22;373(17):1597-606
27783551 - J Manag Care Spec Pharm. 2016 Nov;22(11):1224-1246
19940413 - Postgrad Med. 2009 Nov;121(6):9-20
23251132 - Front Endocrinol (Lausanne). 2012 Dec 17;3:153
21738645 - PLoS One. 2011;6(6):e21368
24626193 - PLoS One. 2014 Mar 13;9(3):e89867
22972108 - Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007400
21684382 - Lancet. 2011 Jun 18;377(9783):2115-26
28392139 - Vaccine. 2017 May 9;35(20):2694-2700
11469529 - Scand J Rheumatol. 2001;30(3):169-71
15374852 - Ann Rheum Dis. 2005 May;64(5):682-7
18401346 - Nat Rev Mol Cell Biol. 2008 May;9(5):367-77
27618156 - Neuroepidemiology. 2016;47(2):82-93
28288484 - Ann Intern Med. 2017 Apr 18;166(8):572-578
3377350 - Ann Intern Med. 1988 Jul 1;109 (1):18-24
22441236 - Postgrad Med J. 2012 Apr;88(1038):240-2
27196460 - Medicine (Baltimore). 2016 May;95(20):e3585
26701199 - Comput Methods Programs Biomed. 2016 Mar;125:58-65
References_xml – ident: ref39
– volume: 166
  start-page: 572
  issue: 8
  year: 2017
  ident: ref19
  article-title: Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes
  publication-title: Ann Intern Med
  doi: 10.7326/M16-2937
– year: 2000
  ident: ref24
  article-title: ICD-9-CM English-Chinese Dictionary
– volume: 22
  start-page: 1118
  issue: 6
  year: 1995
  ident: ref30
  article-title: Association between metabolic factors and knee osteoarthritis in women: the Chingford Study
  publication-title: J Rheumatol
– start-page: CD007400
  issue: 9
  year: 2012
  ident: ref14
  article-title: Topical NSAIDs for chronic musculoskeletal pain in adults
  publication-title: Cochrane Database Syst Rev
– volume: 64
  start-page: 682
  issue: 5
  year: 2005
  ident: ref1
  article-title: Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study)
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2004.023564
– volume: 3
  start-page: 153
  year: 2012
  ident: ref10
  article-title: Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator
  publication-title: Front Endocrinol (Lausanne)
  doi: 10.3389/fendo.2012.00153
– volume: 47
  start-page: 82
  issue: 2
  year: 2016
  ident: ref22
  article-title: Are Chronic Periodontitis and Gingivitis Associated with Dementia? A Nationwide, Retrospective, Matched-Cohort Study in Taiwan
  publication-title: Neuroepidemiology
  doi: 10.1159/000449166
– volume: 54
  start-page: 3212
  issue: 10
  year: 2006
  ident: ref33
  article-title: A prospective population-based study of the predictors of undergoing total joint arthroplasty
  publication-title: Arthritis Rheum
  doi: 10.1002/art.22146
– volume: 70
  start-page: 1354
  issue: 8
  year: 2011
  ident: ref9
  article-title: Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2010.146399
– volume: 351
  start-page: h5983
  year: 2015
  ident: ref2
  article-title: Association of hip pain with radiographic evidence of hip osteoarthritis: diagnostic test study
  publication-title: BMJ
  doi: 10.1136/bmj.h5983
– volume: 66
  start-page: S46
  issue: 4 Suppl
  year: 2017
  ident: ref38
  article-title: Hot Topics in Primary Care: Medication Adherence in Type 2 Diabetes Mellitus: Real-World Strategies for Addressing a Common Problem
  publication-title: J Fam Pract
– volume: 22
  start-page: 1224
  issue: 11
  year: 2016
  ident: ref36
  article-title: A Systematic Review of Insulin Adherence Measures in Patients with Diabetes
  publication-title: J Manag Care Spec Pharm
  doi: 10.18553/jmcp.2016.22.11.1224
– volume: 22
  start-page: 363
  issue: 3
  year: 2014
  ident: ref13
  article-title: OARSI guidelines for the non-surgical management of knee osteoarthritis
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2014.01.003
– volume: 1
  start-page: 563
  issue: 4
  year: 2010
  ident: ref23
  article-title: Taiwan's healthcare report 2010
  publication-title: EPMA J
  doi: 10.1007/s13167-010-0056-8
– volume: 125
  start-page: 58
  year: 2016
  ident: ref27
  article-title: Development of a web-based liver cancer prediction model for type II diabetes patients by using an artificial neural network
  publication-title: Comput Methods Programs Biomed
  doi: 10.1016/j.cmpb.2015.11.009
– volume: 121
  start-page: 9
  issue: 6
  year: 2009
  ident: ref4
  article-title: Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data
  publication-title: Postgrad Med
  doi: 10.3810/pgm.2009.11.2073
– volume: 38
  start-page: 921
  issue: 5
  year: 2011
  ident: ref8
  article-title: Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.100569
– volume: 95
  start-page: e3585
  issue: 20
  year: 2016
  ident: ref16
  article-title: Efficacy and Safety of Celecoxib Therapy in Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000003585
– volume: 9
  start-page: e89867
  issue: 3
  year: 2014
  ident: ref28
  article-title: Increased risk of major depression in the three years following a femoral neck fracture—a national population-based follow-up study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0089867
– volume: 789
  start-page: 60
  year: 2016
  ident: ref21
  article-title: Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2016.07.012
– volume: 2
  start-page: e000435
  issue: 1
  year: 2012
  ident: ref18
  article-title: What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2011-000435
– volume: 12
  start-page: 267
  issue: 3
  year: 2014
  ident: ref37
  article-title: A systematic review of osteoporosis medication adherence and osteoporosis-related fracture costs in men
  publication-title: Appl Health Econ Health Policy
  doi: 10.1007/s40258-013-0078-1
– volume: 7
  start-page: 13
  year: 1961
  ident: ref6
  article-title: Association of osteoarthritis and diabetes mellitus
  publication-title: Tufts Folia Med
– volume: 373
  start-page: 1597
  issue: 17
  year: 2015
  ident: ref17
  article-title: A Randomized, Controlled Trial of Total Knee Replacement
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1505467
– volume: 60
  start-page: 2381
  issue: 8
  year: 2009
  ident: ref35
  article-title: Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24757
– volume: 1
  start-page: e000077
  issue: 1
  year: 2015
  ident: ref11
  article-title: Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis
  publication-title: RMD Open
  doi: 10.1136/rmdopen-2015-000077
– volume: 23
  start-page: 1513
  issue: 9
  year: 2015
  ident: ref32
  article-title: Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis
  publication-title: Osteoarthritis Cartilage
  doi: 10.1016/j.joca.2015.04.026
– volume: 35
  start-page: 2694
  issue: 20
  year: 2017
  ident: ref20
  article-title: Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2017.03.078
– volume: 9
  start-page: 367
  issue: 5
  year: 2008
  ident: ref25
  article-title: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
  publication-title: Nature reviews Molecular cell biology
  doi: 10.1038/nrm2391
– volume: 377
  start-page: 2115
  issue: 9783
  year: 2011
  ident: ref12
  article-title: Osteoarthritis: an update with relevance for clinical practice
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60243-2
– volume: 88
  start-page: 240
  issue: 1038
  year: 2012
  ident: ref31
  article-title: Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype
  publication-title: Postgrad Med J
  doi: 10.1136/pgmj.2010.146399rep
– volume: 366
  start-page: 1059
  issue: 9491
  year: 2005
  ident: ref5
  article-title: The metabolic syndrome—a new worldwide definition
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67402-8
– volume: 109
  start-page: 18
  issue: 1
  year: 1988
  ident: ref34
  article-title: Obesity and knee osteoarthritis. The Framingham Study
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-109-1-18
– volume: 36
  start-page: 403
  issue: 2
  year: 2013
  ident: ref29
  article-title: Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study
  publication-title: Diabetes Care
  doi: 10.2337/dc12-0924
– volume: 30
  start-page: 169
  issue: 3
  year: 2001
  ident: ref7
  article-title: Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study
  publication-title: Scand J Rheumatol
  doi: 10.1080/030097401300162969
– volume: 6
  start-page: e21368
  issue: 6
  year: 2011
  ident: ref26
  article-title: Cancer risk associated with insulin glargine among adult type 2 diabetes patients—a nationwide cohort study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0021368
– volume: 69
  start-page: 761
  issue: 4
  year: 2010
  ident: ref3
  article-title: Association between weight or body mass index and hand osteoarthritis: a systematic review
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.106930
– volume: 43
  start-page: 378
  issue: 2
  year: 2000
  ident: ref15
  article-title: Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: a survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2
– reference: 10693878 - Arthritis Rheum. 2000 Feb;43(2):378-85
– reference: 23251132 - Front Endocrinol (Lausanne). 2012 Dec 17;3:153
– reference: 25987541 - Osteoarthritis Cartilage. 2015 Sep;23(9):1513-22
– reference: 27196460 - Medicine (Baltimore). 2016 May;95(20):e3585
– reference: 26535137 - RMD Open. 2015 Jun 02;1(1):e000077
– reference: 21474484 - Ann Rheum Dis. 2011 Aug;70(8):1354-6
– reference: 24477429 - Appl Health Econ Health Policy. 2014 Jun;12(3):267-77
– reference: 24462672 - Osteoarthritis Cartilage. 2014 Mar;22(3):363-88
– reference: 19487215 - Ann Rheum Dis. 2010 Apr;69(4):761-5
– reference: 22357571 - BMJ Open. 2012 Feb 22;2(1):e000435
– reference: 3377350 - Ann Intern Med. 1988 Jul 1;109 (1):18-24
– reference: 11469529 - Scand J Rheumatol. 2001;30(3):169-71
– reference: 27783551 - J Manag Care Spec Pharm. 2016 Nov;22(11):1224-1246
– reference: 19644856 - Arthritis Rheum. 2009 Aug;60(8):2381-9
– reference: 28392139 - Vaccine. 2017 May 9;35(20):2694-2700
– reference: 23002084 - Diabetes Care. 2013 Feb;36(2):403-9
– reference: 24626193 - PLoS One. 2014 Mar 13;9(3):e89867
– reference: 21324967 - J Rheumatol. 2011 May;38(5):921-30
– reference: 27618156 - Neuroepidemiology. 2016;47(2):82-93
– reference: 26488691 - N Engl J Med. 2015 Oct 22;373(17):1597-606
– reference: 13782559 - Tufts Folia Med. 1961 Jan-Mar;7:13-9
– reference: 26701199 - Comput Methods Programs Biomed. 2016 Mar;125:58-65
– reference: 18401346 - Nat Rev Mol Cell Biol. 2008 May;9(5):367-77
– reference: 28288484 - Ann Intern Med. 2017 Apr 18;166(8):572-578
– reference: 22972108 - Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007400
– reference: 19940413 - Postgrad Med. 2009 Nov;121(6):9-20
– reference: 21684382 - Lancet. 2011 Jun 18;377(9783):2115-26
– reference: 23199110 - EPMA J. 2010 Dec;1(4):563-85
– reference: 26631296 - BMJ. 2015 Dec 02;351:h5983
– reference: 7674240 - J Rheumatol. 1995 Jun;22(6):1118-23
– reference: 15374852 - Ann Rheum Dis. 2005 May;64(5):682-7
– reference: 21738645 - PLoS One. 2011;6(6):e21368
– reference: 27397427 - Eur J Pharmacol. 2016 Oct 15;789:60-67
– reference: 28375408 - J Fam Pract. 2017 Apr;66(4 Suppl):S46-S51
– reference: 22441236 - Postgrad Med J. 2012 Apr;88(1038):240-2
– reference: 16182882 - Lancet. 2005 Sep 24-30;366(9491):1059-62
– reference: 17009255 - Arthritis Rheum. 2006 Oct;54(10):3212-20
SSID ssj0053866
Score 2.4997113
Snippet Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their impact on...
Background Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their...
Background Osteoarthritis (OA) is the most common form of arthritis associated with an increased prevalence of type 2 diabetes mellitus (T2DM), however their...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0191242
SubjectTerms Aged
Aged, 80 and over
Analysis
Antidiabetics
Arthritis
Arthroplasty, Replacement - statistics & numerical data
Biocompatibility
Biology and Life Sciences
Cohort analysis
Cohort Studies
COX-2 inhibitors
Cyclooxygenase 2 Inhibitors - administration & dosage
Cyclooxygenase-2
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Dosage and administration
Drug Therapy, Combination
Female
Hazards
Health insurance
Humans
Hypoglycemic Agents - administration & dosage
Inflammation
Insulin resistance
Insurance
Joint replacement
Joint replacement surgery
Male
Medicine and Health Sciences
Metformin
Metformin - administration & dosage
Middle Aged
Osteoarthritis
Osteoarthritis - complications
Osteoarthritis - drug therapy
Osteoarthritis - surgery
Patients
People and Places
Proportional Hazards Models
Regression analysis
Retrospective Studies
Social Sciences
Subgroups
Surgery
Systematic review
Taiwan
Therapy
Type 2 diabetes
Urbanization
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdQn3hBjK8VChiEBEjLlsauk_BWJqaBBJOgoL5F_lyDhlO1qfY_8Vdy53xoQZPGA1Kf4nOSnu98v3POPxPyyqWpYcYlEc-sjPjU2ig3jEeJTdJEJZI5iYni5y_i9Dv_tJwtrxz1hTVhDT1wo7gjpjlEFIjSSSa4jhM1jZkULnMQuUWuAzSCmNclU80cDF4sRLtRjqXTo3ZcDteVt4cAaiCoJYNAFPj6-1l5tL6ottdBzr8rJ6-EopO75E6LIem8efc9csv6e2Sv9dItfdNSSb-9T36Du0PqG7RPj8-WUUJLvyoVuPGGSm_oL1sjai09RZ5NvwPkSZE8glaO_qxKX9ONDWVbuIgIfSnuCalAa6tAhkRxGZd267fv6Jw2z7osjT2ArvWm6rZyHlDAxmAhJsIzeTc1DcS2eMuFLC-lf0AWJx8Wx6dRezpDpEWe1BEASeNipWINPzbVQkrHjI0NtxpwFG7w5fk0V8YJnTGZcxW7FPoAhFBwmT0kIw_DsU9oLkxuIW8zmQA8p5xinBvITA2yiYENjQnrRqrQLXM5HqBxUYTPcSlkMI3iCxzfoh3fMYn6XuuGueMG-fdoBL0s8m6HC2CNRWuNxU3WOCbP0YSKZhNrP3sU81mYGiE_G5OXQQK5NzwW95zL3XZbfDz78Q9C374OhF63Qq4CdWjZbqiA_4ScXgPJyUASZhA9aN5Hg--0si2wqBM_uQpQyqRzguubX_TNeFMs2PO22jUyLMOP4GPyqPGZXrOAMAHnz-C56cCbBqoftvhyFajPZymYVBY__h9j9YTcBvSLpZwARCZkVG929ikgzFo9C5PJH3AOezc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLage-EFMW7rGGAQEiAtWxqnTsIL6qZNA4kNjYL6Fjm-rEHDKUmq_Sd-JeckTiBoAqQ-xcdJ6nPJd-zjz4S8MFGkmDKBF8ZaeOFEay9RLPQCHURBFghmBCaKH075yefw_WK6cBNulSur7GJiE6hVIXGOfB8LzXAZiAdvV989PDUKV1fdERo3yQaE4Hg6IhsHR6cfz7tYDN7Mudswx6LJvtPP3qqweg_ADXzcgsEHqeHt76PzaHVZVNdBzz8rKH_7JB3fIbcdlqSzVvmb5Ia2d8mm89aKvnKU0q_vkR_g9pACN1qgh2cLL6C5XeYZuHNJhVX0m64RveaWIt-mXQMCpUgiQQtDvxa5rWmpm_ItnEyEvhT3hhRgdsuGFInidC7t5nHf0Bltn3WVK70LXeuy6LZ07lLAyGApysOzecuaNgS3eMu5yK-EvU_mx0fzwxPPndLgSZ4EtQeAUhk_y3wJPzaRXAjDlPZVqCXgKdzoGyaTJFOGy5iJJMx8E0EfgBIZXGYPyMiCOrYITbhKNORvKuaA6zKTsTBUkKEqZBUDWxoT1mkqlY7BHA_SuEybZbkIMpl24FPUb-r0OyZe32vVMnj8Q_4AjaCXRf7t5kJRXqTOnVMmQ8A5gB2DmIfSD7KJzwQ3sQE8yRMpxuQpmlDabmbto0g6mzYhEvK0MXneSCAHh8Uinwuxrqr03dmX_xD6dD4QeumETAHDIYXbWAH_Cbm9BpI7A0mIJHLQvIUG341Klf7yOejZOcH1zc_6ZrwpFu5ZXaxbGRbjYviYPGx9ph9ZQJqA96fw3GjgTYOhH7bYfNlQoE8jMKnY3_77az0itwDfYrEmQI0dMqrLtX4MGLLOnrhA8RNo7nV6
  priority: 102
  providerName: ProQuest
Title Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan
URI https://www.ncbi.nlm.nih.gov/pubmed/29385156
https://www.proquest.com/docview/1993012262
https://www.proquest.com/docview/1993383891
https://pubmed.ncbi.nlm.nih.gov/PMC5791980
https://doaj.org/article/3c48535622864c02b103a6f8f05669ca
http://dx.doi.org/10.1371/journal.pone.0191242
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZG98ILYtzWUYpBSIC0VEmc5oKEUFetDKRtaHSob5ET22tQSUqSavCX-JWc41xEUBGTqjzEx456fM7xd3z5TMgL5XmCCWUbji-54VhSGoFgjmFL27MjmzPFMVE8PXNPLp2Pi_FihzR3ttYKLLamdnif1GW-Gv34_vMdOPxbfWuDZzWVRusslSOALDBkQVDehbHJRTs_ddp1BfBuvXqJqMVwbZPVh-n-1UpnsNKc_m3k7q1XWbENlv69u_KP4Wp2l9ypcSadVIaxR3Zkeo_s1Z5c0Fc13fTr--QXhARIj3UP0en5wrBpki6TCFw9pzwV9JssEdkmKUUuznQD6JQiwQTNFP2aJWlJc6m3duFEI9SleG4kA5NcasIkilO9tJnjfUMntPrWdSLkIVQt86w57nlIAT-DFQkD7-3NS6rJb7HJOU-uefqAzGfH8-mJUd_gYMRuYJcGgE2hzCgyY_gxK3Y5V0xIUzgyBqyFh4CdwAoiodzYZzxwIlN5UAdgRgSv2UPSS6E79gkNXBFIyO2E7wLmi1TEHEdA9iqQcQzsrE9Y01NhXLOb4yUbq1Av2XmQ5VSKD7F_w7p_-8Roa60rdo__yB-hEbSyyM2tX2T5VVi7eshiBzAQ4Erbd53YtCPLZNxVvgKs6QYx75OnaEJhddC1jTDhZKzDJ-RwffJcSyA_R4obgK74pijCD-dfbiD0-aIj9LIWUhmoI-b1oQv4T8j71ZEcdCQhysSd4n00-EYrRYgbP3FZ1gWlDBon2F78rC3GRnFTXyqzTSXDfFwo75NHlc-0mgUUCrnAGL7rdbypo_puSZosNT362AOT8s2DmyjxMbkNCBi3cwIYGZBemW_kE0CZZTQkt7yFB09_auFz9n5Ido-Ozz5dDPW8zVAHlt_03IME
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGeYAXxPhaYTCDQIC0bKmd5gMJoTIoLfuSRkF9i5zYXoOGU5pUFf8SEv8jd_mCoAl4mdSn-Jy2vvPPv7PvzoQ81p4nudTMcnwlLKenlBVI7lhMMY9FTHAt0FE8PHJHH5330_50jfyoc2EwrLLGxAKoZRrjHvkuBprhMZDLXs2_WnhrFJ6u1ldolGaxr76twGXLXo7fgH6fMDZ8O9kbWdWtAlbsBiy3gABJbUeRHcOH92JXCM2lsqWjYlj_MTHVCXpBJLUb-1wETmRrD_rA0hfBYw6vvUQuO5wHWKrfH76rgR-gw3Wr7Dzu9XYrY9iZp0btAJOClZS1Vr_ikoBmKejMz9LsPJ77Z7jmb-vf8Dq5VhFXOigtbZ2sKXODrFfQkNFnVf3q5zfJd8AY8LcLldO946nFaGJmSQTYsaDCSPpF5UiVE0OxuKdZAt2lWLGCppp-ThOT04UqYsVw5xL6UkxEScHGZ0UFJop7x7TeNH5BB7T8rlUi1TZ0zRdpnT-6TYGQg1lKCy8CXuS0qKaLr5yIZCXMLTK5COXdJh0D6tggNHBloMBZlL4LJDLSEXccCe6wxBJmYLhdwmtNhXFVLh1v7TgLizNAD9ymcuBD1G9Y6bdLrKbXvCwX8g_512gEjSwW-y4epIvTsMKOkMcOkCogqsx3ndhmUc_mwtW-BvLqBrHoki00obDMnG0gKxz0CzwGp7BLHhUSWPDDYETRqVhmWTg-_vQfQh9OWkJPKyGdwnDEosrigP-EhcRakpstSYCtuNW8gQZfj0oW_prg0LOeBOc3P2ya8aUYJWhUuixluI8n711yp5wzzcgCrQXnog_f67VmU2vo2y0mmRX11vsemJRv3_37z9oiV0aTw4PwYHy0f49cBWKNUaLAcTZJJ18s1X0gr3n0oIAMSsILhqifwgaw5A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1tb9MwELZGJyG-IMbbCoMZBAKkZU3tNC9ICHUv1cpgm7aC-i1yYnsNGklJU1X8Jf4B_467xCkETcCXSf0Un9PWPj_3nH13JuSZ9jzJpWaW4ythOV2lrEByx2KKeSxigmuBjuKHI_fgo_Nu3BuvkB91LgyGVdaYWAK1zGLcI-9goBkeA7mso01YxMne4O30q4U3SOFJa32dRqUih-rbAty32ZvhHsz1c8YG-6PdA8vcMGDFbsAKC8iQ1HYU2TF8eDd2hdBcKls6KgYugEmqTtANIqnd2OcicCJbe9AHzGAEjzm89hpZ9cAo-i2yurN_dHJamwEAEtc1uXrc63aMamxPs1RtA68Cu8oatrC8MmBpGFrTi2x2Gev9M3jzN2s4uEVuGhpL-5XerZEVld4mawYoZvSlqWb96g75DogD3nepAHT3eGwxmqSTJAIkyalIJf2iCiTOSUqx1Gc6B_JLsX4FzTT9nCVpQXNVRo7hPib0pZiWkoHGT8p6TBR3kmm9hfya9mn1XYtEqi3oWuRZnU26RYGeg5JKC68Fzgta1tbFV45EshDpXTK6ium7R1opTMc6oYErAwWuo_RdoJSRjrjjSHCOJRY0AzVuE17PVBib4ul4h8dFWJ4IeuBEVQMf4vyGZn7bxFr2mlbFQ_4hv4NKsJTF0t_lgyw_Dw2ShDx2gGIBbWW-68Q2i7o2F672NVBZN4hFm2yiCoVVHu0SwMJ-r0RncBHb5GkpgeU_UlxI52I-m4XD40__IXR22hB6YYR0BsMRC5PTAf8Jy4o1JDcakgBicaN5HRW-HpVZ-Gu5Q896EVze_GTZjC_FmMFUZfNKhvt4Dt8m96s1sxxZILngavTge73GamoMfbMlTSZl9fWeByrl2w_-_rM2yXWAp_D98OjwIbkBLBtDRoHwbJBWkc_VI2CyRfTYYAYl4RWj1E8usbZ_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combination+COX-2+inhibitor+and+metformin+attenuate+rate+of+joint+replacement+in+osteoarthritis+with+diabetes%3A+A+nationwide%2C+retrospective%2C+matched-cohort+study+in+Taiwan&rft.jtitle=PloS+one&rft.au=Lu%2C+Chieh-Hua&rft.au=Chung%2C+Chi-Hsiang&rft.au=Lee%2C+Chien-Hsing&rft.au=Hsieh%2C+Chang-Hsun&rft.date=2018-01-31&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=13&rft.issue=1&rft.spage=e0191242&rft_id=info:doi/10.1371%2Fjournal.pone.0191242&rft.externalDBID=IOV&rft.externalDocID=A525787306
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon